UPC APP 28226/2025

—·EP1970677: Intravenous infusion system with dosing device

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Akteneinsicht (RoP262)
Parteien: Kläger
F. Hoffmann-La Roche AG
Roche Diabetes Care GmbH
Vertreter: Christof Augenstein (Kather Augenstein); Sophie Prudent (Kather Augenstein); Katharina Brandt (Kather Augenstein)
Beklagte
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
VitalAire GmbH
Dinno Santé s.a.i.
Air Liquide Healthcare Nederland B.V.
Rubin Medical ApS
Vertreter: Roland Küppers (Taylor Wessing); Alexander Rubusch (Taylor Wessing); Christine Kanz (Hoyng Rokh Monegier)
Division: Dusseldorf LD
Richter: —
Technology: Measurement & Testing
Sprache: —
Erste Entscheidung: 18. Juni 2025

Entscheidungen

2025-06-18
Application RoP262A
Procedural order from the Düsseldorf Local Division (UPC_CFI_504/2023) on Roche's application for confidentiality protection under R. 262A RoP in proceedings against Tandem Diabetes Care and others concerning EP 1 970 677. The order addressed composition of the confidential club and access rights for multiple defendants and their representatives.
Rechtsfragen:Confidentiality protection (R. 262A RoP)Confidential club membership for multiple defendants

Dokumente